Hepatitis B surface antigen (HBsAg) prevalence (%) in East Timor
East Timor: Hepatitis B surface antigen (HBsAg) prevalence was 1.0% in 2024. ▼ Falling
Hepatitis B surface antigen (HBsAg) prevalence in East Timor, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in East Timor is 1.0%, measured in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 28.6% on the previous year and down 69.7% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in East Timor peaked at 3.3% in 2015 and was at its lowest, 1.0%, in 2024.
That places East Timor 31st out of 194 countries with data for 2024, putting it in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in East Timor, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 3.3% | — |
| 2016 | 2.8% | -15.2% |
| 2017 | 2.3% | -17.9% |
| 2018 | 2.1% | -8.7% |
| 2019 | 1.8% | -14.3% |
| 2020 | 1.5% | -16.7% |
| 2021 | 1.4% | -6.7% |
| 2022 | 1.4% | +0.0% |
| 2023 | 1.4% | +0.0% |
| 2024 | 1.0% | -28.6% |
East Timor compared with similar countries
- East Timor's 1.0% is above the median for lower middle income countries, which is 0.6%, 1.7× the median. (47 countries reporting)
- East Timor's 1.0% is above the median for East Asia & Pacific, which is 0.6%, 1.7× the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.5% | 1.8% | 3.3% | 5 |
| 2020s | 1.3% | 1.0% | 1.5% | 5 |
Countries ranked near East Timor
More health data for East Timor
- Un projection of annual infant deaths, annual growth rate -1.22 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.894 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,287 deaths per 1,000 people (2090)
- Number of infants who die before age 1 162 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.051 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.04 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in East Timor?
- Hepatitis b surface antigen (hbsag) prevalence in East Timor was 1.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in East Timor?
- The highest recorded value was 3.3% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in East Timor?
- The lowest recorded value was 1.0% in 2024.
- How does East Timor rank for hepatitis b surface antigen (hbsag) prevalence?
- East Timor ranks 31st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in East Timor?
- Over the last ten years it is down 69.7%. The long-run trend across the full record is falling.
- Where does this East Timor data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).